BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28968020)

  • 1. [Molecular characterization of Cryptococcus neoformans isolates from HIV patients, Guayaquil, Ecuador].
    Sánchez S; Zambrano D; García M; Bedoya C; Fernández C; Illnait-Zaragozí MT
    Biomedica; 2017 Sep; 37(3):425-430. PubMed ID: 28968020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptococcus tetragattii as a major cause of cryptococcal meningitis among HIV-infected individuals in Harare, Zimbabwe.
    Nyazika TK; Hagen F; Meis JF; Robertson VJ
    J Infect; 2016 Jun; 72(6):745-752. PubMed ID: 27038502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients.
    Bertout S; Drakulovski P; Kouanfack C; Krasteva D; Ngouana T; Dunyach-Rémy C; Dongtsa J; Aghokeng A; Delaporte E; Koulla-Shiro S; Reynes J; Mallié M
    Clin Microbiol Infect; 2013 Aug; 19(8):763-9. PubMed ID: 23033854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcus neoformans isolates from Yaoundé human immunodeficiency virus-infected patients exhibited intra-individual genetic diversity and variation in antifungal susceptibility profiles between isolates from the same patient.
    Kammalac Ngouana T; Drakulovski P; Krasteva D; Kouanfack C; Reynes J; Delaporte E; Boyom FF; Mallié M; Bertout S
    J Med Microbiol; 2016 Jul; 65(7):579-589. PubMed ID: 27100672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patients.
    Kassi FK; Drakulovski P; Bellet V; Krasteva D; Gatchitch F; Doumbia A; Kouakou GA; Delaporte E; Reynes J; Mallié M; Menan HIE; Bertout S
    Mycoses; 2016 Dec; 59(12):811-817. PubMed ID: 27461533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype and mating type distribution within clinical Cryptococcus neoformans and Cryptococcus gattii isolates from patients with cryptococcal meningitis in Uberaba, Minas Gerais, Brazil.
    Mora DJ; Pedrosa AL; Rodrigues V; Leite Maffei CM; Trilles L; Dos Santos Lazéra M; Silva-Vergara ML
    Med Mycol; 2010 Jun; 48(4):561-9. PubMed ID: 19905964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypes of Cryptococcus neoformans and Cryptococcus gattii as agents of endemic cryptococcosis in Teresina, Piauí (northeastern Brazil).
    Martins LM; Wanke B; Lazéra Mdos S; Trilles L; Barbosa GG; Macedo RC; Cavalcanti Mdo A; Eulálio KD; Castro JA; Silva AS; Nascimento FF; Gouveia VA; Monte SJ
    Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):725-30. PubMed ID: 22012227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization and antifungal susceptibility of Cryptococcus neoformans strains collected from a single institution in Lima, Peru.
    Bejar V; Tello M; García R; Guevara JM; Gonzales S; Vergaray G; Valencia E; Abanto E; Ortega-Loayza AG; Hagen F; Gutierrez EL
    Rev Iberoam Micol; 2015; 32(2):88-92. PubMed ID: 25556051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire].
    Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J
    Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii.
    Bovers M; Hagen F; Kuramae EE; Diaz MR; Spanjaard L; Dromer F; Hoogveld HL; Boekhout T
    FEMS Yeast Res; 2006 Jun; 6(4):599-607. PubMed ID: 16696655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients.
    Feng X; Yao Z; Ren D; Liao W; Wu J
    FEMS Yeast Res; 2008 Sep; 8(6):930-8. PubMed ID: 18671745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilocus sequence typing of Cryptococcus neoformans in non-HIV associated cryptococcosis in Nagasaki, Japan.
    Mihara T; Izumikawa K; Kakeya H; Ngamskulrungroj P; Umeyama T; Takazono T; Tashiro M; Nakamura S; Imamura Y; Miyazaki T; Ohno H; Yamamoto Y; Yanagihara K; Miyzaki Y; Kohno S
    Med Mycol; 2013 Apr; 51(3):252-60. PubMed ID: 22901045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.
    Kangogo M; Bader O; Boga H; Wanyoike W; Folba C; Worasilchai N; Weig M; Groß U; Bii CC
    Mycoses; 2015 Nov; 58(11):665-70. PubMed ID: 26404188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis of cryptococcal meningitis in cerebrospinal fluid: comparison of primer sets for Cryptococcus neoformans and Cryptococcus gattii species complex.
    Martins Mdos A; Brighente KB; Matos TA; Vidal JE; Hipólito DD; Pereira-Chioccola VL
    Braz J Infect Dis; 2015; 19(1):62-7. PubMed ID: 25523072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cryptococcus neoformans isolated from patients with AIDS].
    Fernandes Ode F; Costa TR; Costa MR; Soares AJ; Pereira AJ; Silva Mdo R
    Rev Soc Bras Med Trop; 2000; 33(1):75-8. PubMed ID: 10881122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization and antifungal susceptibility testing of Cryptococcus neoformans sensu stricto from southern Brazil.
    Herkert PF; Meis JF; Lucca de Oliveira Salvador G; Rodrigues Gomes R; Aparecida Vicente V; Dominguez Muro M; Lameira Pinheiro R; Lopes Colombo A; Vargas Schwarzbold A; Sakuma de Oliveira C; Simão Ferreira M; Queiroz-Telles F; Hagen F
    J Med Microbiol; 2018 Apr; 67(4):560-569. PubMed ID: 29461182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya.
    Bii CC; Makimura K; Abe S; Taguchi H; Mugasia OM; Revathi G; Wamae NC; Kamiya S
    Mycoses; 2007 Jan; 50(1):25-30. PubMed ID: 17302744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
    Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
    Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.